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Background: The World Health Organisation stresses the need to collect high quality longitudinal data on
rehabilitation and to improve the comparability between studies. This implies using all the information available
and transparent reporting. We therefore investigated the quality of reported or planned randomised controlled
trials on rehabilitation post-stroke with a repeated measure of physical functioning, provided recommendations on
the presentation of results using regression parameters, and focused on the difficulties of adjustment for baseline
outcome measures.
Methods: We performed a systematic review of the literature from 2011 to 2013 and collected information on the
way data was analysed. Moreover we described various approaches to analyse the data using mixed models
illustrated with real data.
Results: Eighty-four eligible studies were identified of which 61 % (51/84) failed to analyse the data longitudinally.
Moreover, for 30 % (25/83) the method for adjustment for baseline is not known or not existent. Using real data we
were able to show how much difference in results an adjustment for baseline data can make. We showed how to
provide interpretable intervention effects using regression coefficients while making use of all the information
available in the data.
Conclusions: Our review showed that improvements were needed in the analysis of longitudinal trials in rehabilitation
post-stroke in order to maximise the use of collected data and improve comparability between studies. Reporting fully
the method used (including baseline adjustment) and using methods like mixed models could easily achieve this.
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In 2011, the World Health Organisation (WHO) pub-
lished their World Report on Disability [1], providing a
framework “for disability data collection related to policy
goals of participation, inclusion, and health. [Using it]
will help create better data design and also ensure that
different sources of data relate well to each other” (p. 45).
In the rehabilitation chapter of this report, the lack of
randomised trials in rehabilitation research is mentioned* Correspondence: odile.sauzet@uni-bielefeld.de
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creativecommons.org/publicdomain/zero/1.0/and the necessity of collecting comparable outcomes from
various sources is pointed out. The report mentions
the importance of longitudinal data to understand the
“dynamic of disability”. Consequently, it is important in
rehabilitation research not only to collect quality data
but also to make the best use of it. This includes using
all the (statistical) information contained in the data
collected, providing the maximal transparency in the
description of the methodology, and presenting inform-
ative intervention effects.
In order to reflect the dynamic nature of an inter-
vention, the analysis of repeated measures must take the
longitudinal nature of the data into account. This presentsticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Table 1 Description of studies
Body function outcome Primary only 19 % (16/84)
Secondary only 6 % (5/84)
Primary and secondary 56 % (47/84)




Number of arms 2 81 % (68/84)
Number of patients
per arm
Median (range) 18.8 (6–182)




Cross-over design 5 % (4/84)
Duration of follow-up median (range) of duration 3 (0.3–60) months
Number of follow-up
measures
2 55 % (46/84)
4 35 % (29/84)
Other (3,5, unclear) 11 % (9/84)
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reported by the same patients. Another less well known
difficulty concerns adjusting the effect of intervention for
the reduction to mean using baseline outcome values [2].
Moreover, the interpretability of results is paramount for
the comparability between studies. Reporting regression
parameters with confidence intervals rather than p-values
allows the interpretation of the effectiveness of an inter-
vention in term of outcome measures. But this form of
reporting, however, is done rarely [3, 4].
The aim of this paper is to present the results of a sys-
tematic review of the analysis of measures of physical
functioning in randomised controlled trials evaluating
interventions in rehabilitation post-stroke. The reasons
some approaches are sub-optimal are discussed and we
provide recommendations on how to present results
using regression coefficients and confidence intervals
[5–7]. Those recommendations are illustrated with data
from the BOMeN study (Berufliche Orientierung in der
Medizinischen Neurorehabilitation [Occupational Orien-
tation in Medical Neurorehabilitation]), a RCT to evaluate
the effectiveness of a return to work oriented intervention
during residential rehabilitation of stroke and brain
damaged patients [8, 9].
Methods
Review
In December 2013, the databases Medline, Medpilot,
Cochrane Library, and Scopus/SciVerse were searched
for articles reporting RCTs or protocols of RCTs on the
rehabilitation of stroke patients with a measure of phys-
ical functioning. Studies with only one post-intervention
measure, no measure of physical functioning, and brain
injuries not due to a stroke were excluded from the
review. Systematic reviews were also excluded. In order to
reflect recent practices, we restricted our search to articles
published in 2011 or later. The MeSH terms are given in
the online supplement, please see Additional file 1. All
extracted studies were screened independently by two of
the authors for eligibility by reading the title and abstract.
The full texts of all eligible studies were obtained.
Data were collected using a form piloted for consistency,
independently by two of the authors and when entries
were in disagreement, the articles were checked further.
The full list of items extracted from the studies can be
seen in Tables 1, 2 and 3. It included background informa-
tion on the study among which if a baseline measure of
physical functioning was collected, whether the data col-
lected were analysed longitudinally, and the method of
statistical analysis. It was recorded whether a method of
adjustment for baseline measures was described and if an
intervention effect was reported.
The results of the review are presented in descriptive
tables with absolute and relative numbers of articles foreach item. The report of this review follows the PRISMA
checklist [10]. This article being based on a review of
the literature and is methodological in nature therefore
no ethical approval was required.
Models for the analysis of longitudinal data on
rehabilitation
The discussion of the systematic review’s results is illus-
trated with examples and recommendations using mixed
models. We show that the intervention effects can be
reported using regression parameters. We provide sug-
gestions on the presentation of method and results
illustrated with data from the BOMeN study, analysed
using Stata 12 [11]. The BoMeN study (Berufliche
Orientierung in der Medizinischen Neurorehabilitation
[Occupational Orientation in Medical Neurorehabilita-
tion]), was a RCT performed from 2007 to 2009 in two
residential neurological rehabilitation clinics in Germany
which evaluated the effectiveness of a return to work
oriented intervention during residential rehabilitation of
stroke and brain damaged patients. For the BoMeN
study, the approvals of the ethic committee of the Med-
ical chamber of Westfalen-Lippe and of the Faculty of
Medicine of the Westfälischen Wilhelms-Universität
Münster were obtained. Patients recruited included 93
women and 205 men aged 22 to 60 years and 15 to
60 years respectively. The total duration of follow-up
was 15 months after the rehabilitation was concluded.
The intervention consisted among other in a patient
education programme and a better inclusion of work-
place related needs in the therapeutic plan. For more de-
tail see [8, 9]. While the primary aim of the study was to
Table 2 Method of analysis
Measurement of outcome Baseline- 1. After intervention- 2. Follow-up 46 % (39/84)
Othera 54 % (45/84)
aMore follow-ups after intervention or assessment during intervention
Repeated measure data was analysed Cross sectional at each time-point 38 % (32/84)
Longitudinal 39 % (33/84)
Both longitudinal and cross sectional 8 % (7/84)
Repeated data not fully analysed 14 % (12/84)
Method of analysis
Cross sectional t-test 22 % (10/46)
ANOVA/ANCOVA 35 % (16/46)
Regression 7 % (3/46)
Non parametric test/dichotomised data 37 % (17/46)
Correction for multiple testing due to repeated measures 76 % (31/41)
Longitudinal Mixed Model 21 % (7/33)
Repeated measure ANOVA 72 % (24/33)
Generalised Estimating Equations 6 % (2/33)
Results presented
Mean (SD)b at each time-point per group 66 % (47/71)
F values (for ANOVA/ANCOVA) 54 % (19/35)
Regression coefficients 71 % (6/12)
None 8 % (6/71a)
a13 of the 84 studies were protocols. bStandard deviation
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point, the questionnaire FS-36 was also used to collect
information about quality of life. The questionnaire has
been answered at at least one follow-up time by 295 pa-
tients. We computed the physical functioning sub-score
and used in the examples presented here.Table 3 Use of baseline data in the primary analyse of physical
functioning
Baseline data Collected 99 % (83/84)
Method of
adjustment
Mentioned in Methods 64 % (53/83)
If not, mentioned in
Results
6 % (5/83)
No adjustment 13 % (11/83)
Unknown 17 % (14/83)
Use of baseline data
in the
Difference from baseline 33 % (19/58)
analysis Covariate 31 % (18/58)
Time-point 29 % (17/58)
Used to compute a
dichotomised outcome
3 % (2/58)
Unclear 3 % (2/58)Results
We identified 84 eligible studies, 13 of which were
protocols. The complete flowchart is available given as
online supplement, please see Additional file 2. The
study characteristics are presented in Table 1. Most
studies had a measure of physical functioning as a pri-
mary outcome (68/84, 81 %) and 29 % (24/84) presented
multiple primary outcomes in line with the recom-
mendation of the WHO report on disability to reflect
the diversity of the aspect of the International Classifica-
tion of Functioning.
All results regarding the statistical analysis are pre-
sented in Table 2. Only 39 % (33/84) of studies per-
formed a longitudinal analysis of the data. Other studies
analysed the data cross-sectionally (32/84, 38 %), mostly
at each measure time-point, thus losing the dynamics
contained in the data. In twelve studies (14 %) not all
the collected longitudinal data was analysed, thus a con-
siderable amount of information available was ignored.
The results presented for the 71 studies which were
not protocols included mostly mean and standard devia-
tions at each time-point and for each group (47/71,
66 %) but no overall effect of the intervention over time
was ever presented. For almost a third of studies (25/83,
30 %) it is unclear if baseline outcome values were used
in the analysis. For data analysed longitudinally, the
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and 14 studies from 21 used baseline as a time-point in
the regression. Two studies used a change from baseline
in a longitudinal analysis which means that outcomes at
different time-points were not comparable. In all others,
longitudinal analysis baseline was covariate in the model.
Discussion
Our review has shown that baseline measures are con-
sistently collected but not always adjusted for. Moreover,
52 % of studies ignored the longitudinal nature of the
data among which 14 % did not use all the follow-up
data available. This is evidence that a lot of the informa-
tion collected and available is not used. Moreover, ana-
lysis based on the analysis of variance (for example
repeated measures ANOVA) seems to remain popular
even when the limitation of these relative to regression
based method like mixed models have been often pre-
sented in the literature [4, 12].
We outline the difference between analysis of variance
(ANOVA) and regression models. The ANOVA is a gen-
eralisation of the t-test and compare the means of sev-
eral groups of patients. A regression model provides a
relationship between an outcome and some predictors
with an error term. The regression coefficient for the
group effect is the effect of the intervention.
Mixed models are regression models in which the
non-independence of the measures taken on the same
patient is accounted for, in its simplest form, by allowing
the constant in the model (intercept) to vary between
patients (random intercept model). This is described as
a random effect. In such models the effect of the inter-
vention is the same for all and is given by the coefficient
obtained for the intervention group. This is a fixed
effect. Because the model consists of fixed and random
effect, they are called mixed models. In studies with
long-term community based follow-up, the number of
patient with some non-completed follow-up can be
large. Valuable information is nevertheless available for
those patients. Repeated measures ANOVA can only
take into account patients with all follow-up measure-
ments [4]. Mixed models use data from all patients with
at least one post baseline measure [5–7], thus making
the most of the data available. Of course, missing mea-





N No adjustment for baseline va
Middle condition 141 −0.107 (0.064)
Middle + worse condition 173 −0.036 (0.049)
Middle + better condition 181 −0.019 (0.066)place by careful planning and by developing effort to
track down patients who have moved. Another advan-
tage of mixed model is that a large variability between
patients in the actual time the measurement were taken
can be taken into account. This is done by including the
continuous time variable in the model.
A particular study design is motivated by the aims and
the settings of the intervention. An intervention limited in
time because performed in an inpatient medical institution
(hospital or rehabilitation clinic) may have good short-
term effects but the long-term effects are to be evalu-
ated. For long-term community based interventions, the
dynamic of the intervention may be more of interest.
We illustrate the limitations of various approaches
encountered in the review with the physical functioning
score at three weeks, six, 12, and 15 months of the
FS-36 questionnaire from the BOMeN study.
Reduction to mean
We illustrate the effects reduction to the mean using a
mixed model to estimate the overall effect of the inter-
vention over time. Reduction to the mean occurs when
there are some extreme outcome values at baseline
which will see stronger effects than the values close to
the mean. Consider three subsets of our dataset: A. only
patient with scores in a middle range; B. patient with
score in a middle to upper range (add patients with
worse conditions at baseline than in A); C. score in a
lower and middle range (add patient with better condi-
tions at baseline than in A). An overall reduction in
score (negative regression coefficient) indicates an over-
all better physical functioning.
We then compare the group effects: 1. baseline out-
come values are not a covariate and 2. baseline outcome
values are a covariate in the model. For data A, the dif-
ference in effect between 1. (−0.107 (0.064)) and 2.
(−0.112 (0.067)) is small because the baseline values are
homogeneous. For data B (1. -0.036 (0.049) and 2. -
0.028 (0.054)) and data C (1. (−0.019 (0.066) and
2.−0.047 (0.059)) the differences are respectively almost
a third less and twice more when baseline values are
adjusted for (Table 4). This is because in data C, the
patients with perfect physical functioning at baseline
saw no improvement even if the intervention did have
an effect on those who could improve. Not adjusting forno adjustment for baseline outcome values is performed
error) Consequence of the
reduction to the mean
lues Baseline values as a covariate
−0.112 (0.067) No major consequence
−0.028 (0.054) Effect overestimated
−0.047 (0.059) Effect underestimated
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B. the difference is due to the stronger effect seen on
patient with the higher scores. Not adjusting for base-
line meant overestimating the true effect. In data A, the
effects of the reduction to the mean are limited because
no patient had extreme scores. The adjusted effects are
different in the three datasets because they are obtained
on different populations.
Difference from baseline
Redefining the outcome as difference from baseline is
problematic and can be easily avoided. If the data is ana-
lysed longitudinally, then the outcome value has a differ-
ent meaning at each time-point due to the varying time
laps between baseline and time-point. If the analysis is
cross-sectional (i.e., one post intervention measure) then
the best approach is to have baseline as a covariate in
the model [2].
A slope model is suitable to measure the score change
over time. This model provides an overall rate of change
per time unit from baseline or from the first post inter-
vention measurement. It is measured by the slope of the
fitted line relating outcomes values to the continuous
time. It will show if in the intervention group the phys-
ical functioning scores increase faster than in the control
group. The difference in slope between the groups is ob-
tained by estimating a parameter for time-group inter-
action. The rate of change per time unit is estimated
from baseline, then baseline is an outcome time-point.
Using physical functioning score at baseline, three
weeks, six, 12, and 15 months of the FS-36 questionnaire
data from the BOMeN study, we obtained (Table 5) that
the mean score decreases by 0.0011 score points per
week more in the intervention group than in the control
group (confidence interval [−0.0004, 0.0026]).
Cross-sectional analysis at each time-point
Cross-sectional analysis at each time-point should be
avoided because the dynamic within each patient is lost.
There is also a loss of power due the necessary correction




−0.0011 (0.0006) Difference between
the groups in score
decrease per week.




difference t2 - t1
Change in group
difference t3 - t1
Group Group*t2 (categorical)a Group*t3 (categorical)a
−0.098 (0.075) 0.003 (0.081) 0.031 (0.085)
*Interaction termmodel with time as categorical variable with time-group
interactions and baseline outcome values as a covariate.
The model provides an estimate of the intervention effect
at each time-point making a maximal use of the data avail-
able (Table 5).
Using data from the BOMeN study we obtained that
the intervention group had a score lower by 0.097 (SD:
0.072) score points than the control group at the first
time-point (three week). Then at six month this differ-
ence was decreased by 0.0002, i.e., unchanged compared
to three weeks. Then at twelve months, the difference
between the groups is decreased by 0.033 score points
compared to the first time-point to −0.064 score points.
This means that the maximum effect of the intervention
is seen directly at the end of the intervention (three
weeks) and is sustained the first six months and then
decreases.Conclusion and suggestions
Our review has shown that not only the reporting of
RCTs in the rehabilitation post-stroke needs improve-
ment (see recommendation of the CONSORT statement
[13]) but also the method of analysis itself. A lot of col-
lected information was lost. More methods are available
for analysing longitudinal data which were not discussed
here [6, 11]. We have attempted, using real data as an
example, to show the consequences of using some of
approaches which are sub-optimal. We also showed how
results of a regression analysis can be presented in an in-
formative way using regression parameters and confi-
dence intervals. We recommend that, despite limited
publication space, the primary research question should
be clearly stated and the overall intervention effect over
the duration of follow-up should always be reported.
Secondly the intervention effect at the particular follow-
up measurements (estimated from a longitudinal model
with time represented by dummy variables and the inter-
action between time and the intervention variable) can
be reported. Also by using time as a continuous variable
an estimate of the overall rate of change can be ob-
tained. This also applies to study protocols. All covari-
ates and the method of adjustment for baseline should
also be clearly indicated because they influence the esti-
mated intervention effect.Additional files
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